allergic rhinitis
Conditions
Interventions
observation group:Qinglong Duomin Decoction
observation group:Levocetirizine hydrochloride placebo
control group:Levocetirizine Hydrochloride
control group:Qinglong Duomin Decoction placebo
Sponsors
Dongguan Maternal and Child Health Hospital
Eligibility
Sex/Gender
All
Age
3 Years to 14 Years
Inclusion criteria
Inclusion criteria: (1) Those who meet the diagnostic criteria of western medicine and traditional Chinese medicine for allergic rhinitis, voluntarily take the test and sign the informed consent; (2) Age: 3-14 years old, gender is not limited; (3) Those who have not used hormones, immunosuppressants and other related drugs that affect the examination and judgment of experimental results one week before inclusion in this study; (4) The patient gave informed consent and voluntarily followed up with the patient and truthfully fed back the information to the patient;
Exclusion criteria
Exclusion criteria: (1) Those who do not meet any of the inclusion criteria; (2) Those with nasal congestion and runny nose due to other reasons such as colds, nasal polyps, sinusitis, abnormal nasal structure, congenital nasal structure defects, etc.; (3) Patients with serious congenital diseases or wasting diseases of the heart, liver, kidney and nerve, hematopoietic system, or other underlying diseases that affect the judgment and treatment, or patients with mental diseases; (4) Those who are unable to insist on taking medicines and follow-up consultations as required, and who cannot cooperate with feedback information; (5) Those who are participating in clinical trials of other drugs.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| TNSS;VAS;TCM Syndrome Score; | — |
Secondary
| Measure | Time frame |
|---|---|
| TNNSS;Quality of life score for children with allergic rhinitis;serum specific IgE;Nasal Acoustic Reflex Measurement; | — |
Countries
china
Contacts
Public ContactZhang Yanhua
Dongguan Maternal and Child Health Hospital
Outcome results
None listed